Researchers have found a new function of microglia cells in the brain. The findings could lead to new treatments for Alzheimer’s by investigating this function.
Alzheimer’s is a disease that especially strikes people over a certain age and cannot be cured once it arrives. Studies are ongoing to prevent and even treat Alzheimer’s, which is known for its effect on the memory of the person. One of these studies shed light on a new knowledge that will provide an advantage on this path.
A new study has revealed that one of the functions of an immune cell type other than immune defense is inhibiting the development of Alzheimer’s. Research on this cell, which can be associated with many other health problems, may pave the way for the treatment of Alzheimer’s.
Protects vessels whose narrowing can lead to Alzheimer’s
The study, led by researchers from the University of Virginia School of Medicine, has uncovered a hitherto unknown but vital function of a type of cell that protects the brain from disease and damage. These cells, known as microglia, are, according to new information. It regulates blood flow in the brain and protects vital blood vessels.
It is known that the narrowing of blood vessels in the brain causes diseases and health problems such as Alzheimer’s, dementia, cognitive decline and stroke. Ukpong B. Eyo of the University of Virginia Department of Neuroscience explains the results with these words: “Looking at its known function, blood vessels are critical for normal brain function to meet the brain’s extreme energy demands. These findings reveal the previously unknown roles of these brain cells in maintaining proper blood flow to the brain and intervenes in the case of impaired blood flow to the brain.“
RELATED NEWS
How You Drive Could Tell You If You Have Alzheimer’s
Stating that the findings can help find new therapy methods for Alzheimer’s, Eyo continues his explanations as follows: “We are currently extending research into Alzheimer’s disease to find out if this mechanism can be increased to improve blood flow in mouse subjects with this disease. Our hope is that these findings in the lab will improve patient outcomes. transforming into new treatments towards.”